Search filters

List of works by Dorota Danielak

Assessment of the Risk of Rhabdomyolysis and Myopathy During Concomitant Treatment with Ticagrelor and Statins

scientific article published on 01 July 2018

Bioavailability of moclobemide from two formulation tablets in healthy humans

scientific article published on 01 February 2019

Clinical pharmacokinetics of clopidogrel and its metabolites in patients with cardiovascular diseases

scientific article published on February 2014

Correction to: Population pharmacokinetic approach for evaluation of treosulfan and its active monoepoxide disposition in plasma and brain on the basis of a rat model

scientific article published on 12 August 2020

Determinants of high on-treatment platelet reactivity and agreement between VerifyNow and Multiplate assays

scientific article published on 24 February 2017

Development of a Limited Sampling Strategy for the Estimation of Exposure to High-Dose Etoposide After Intravenous Infusion in Pediatric Patients.

scientific article published on 20 December 2016

Development of an LC-MS/MS method for simultaneous determination of ticagrelor and its active metabolite during concomitant treatment with atorvastatin

scientific article published on 16 December 2018

Genetic and non-genetic factors affecting the response to clopidogrel therapy.

scientific article published on 07 March 2012

Genetic factors influencing efficacy of clopidogrel treatment

scientific article

HPCE AND HPLC METHODS FOR DETERMINATION OF CLOPIDOGREL AND ITS CARBOXYLIC ACID METABOLITE IN BIOLOGICAL SAMPLES: A COMPARATIVE ANALYSIS

HPLC–MS/MS method for the simultaneous determination of clopidogrel, its carboxylic acid metabolite and derivatized isomers of thiol metabolite in clinical samples

scientific article published on 12 November 2012

Impact of CYP3A4*1G Allele on Clinical Pharmacokinetics and Pharmacodynamics of Clopidogrel

scientific article published on 18 February 2016

Impact of common ABCB1 polymorphism on pharmacokinetics and pharmacodynamics of clopidogrel and its metabolites

scientific article published on 28 November 2014

Impact of genetic variants of selected cytochrome P450 isoenzymes on pharmacokinetics and pharmacodynamics of clopidogrel in patients co-treated with atorvastatin or rosuvastatin

scientific article published on 02 January 2020

Influence of genetic co-factors on the population pharmacokinetic model for clopidogrel and its active thiol metabolite.

scientific article published on 15 September 2017

Pharmacokinetics and pharmacodynamics of gliclazide from immediate and modified release formulation tablets in rats

scientific article published on January 2014

Population pharmacokinetic approach for evaluation of treosulfan and its active monoepoxide disposition in plasma and brain on the basis of a rat model

scientific article published on 30 May 2020

Population pharmacokinetics of treosulfan and development of a limited sampling strategy in children prior to hematopoietic stem cell transplantation.

scientific article published on 3 October 2017

Relationship between exposure to treosulfan and its monoepoxytransformer – An insight from population pharmacokinetic study in pediatric patients before hematopoietic stem cell transplantation

scientific article published on 27 April 2018

The influence of genetic polymorphism of Cyp2c19 isoenzyme on the pharmacokinetics of clopidogrel and its metabolites in patients with cardiovascular diseases

scientific article published on 06 May 2014

Ticagrelor in modern cardiology - an up-to-date review of most important aspects of ticagrelor pharmacotherapy

scientific article published on 27 December 2017